Eating Disorder Exacts a High Toll on Men Too

New research shows that men who binge eat experience comparable levels of clinical impairment as women, yet remain underrepresented in clinical trials. Medscape Medical News

PSA Screening: Has the Death Knell Been Sounded?

Reactions from prostate cancer experts to the recent recommendation against regular PSA screening have been published. Medscape Medical News

HPV Vaccine Protection Against Anal Disease in Men

The quadrivalent vaccine reduces rates of anal neoplasias in men who have sex with men. Medscape Medical News

Aspirin Chemoprevention Now Recommended in Lynch Syndrome

Results from a decade-long trial show that aspirin taken regularly halved the risk of developing cancer in individuals with this hereditary disorder. Medscape Medical News

AACR-FCPR: A Decade of Progress in Cancer Prevention (with video)

BOSTON (MedPage Today) — In this exclusive interview with MedPage Today, Powell Brown, MD, PhD, chair of the program committee at the 10th annual Frontiers in Cancer Prevention Research conference, looks back over the last 10 years and discusses future challenges.

Lupron Label Updated With Added Puberty Data

WASHINGTON (MedPage Today) — The FDA has approved an updated label — including 18 years of data — for a drug that delays the onset of early puberty.

Deans Dissect Med School Rankings (with video)

NEW YORK (MedPage Today) — A good reputation — even if it doesn’t reflect reality — can do more for a medical school’s “ranking” than program innovation, according to several medical school deans.

FDA Panel Splits on Afib Ablation Devices

(MedPage Today) — An FDA advisory panel gave tepid endorsement to one ablation device for treating atrial fibrillation and rejected another during back-to-back meetings this week.

EU Says Pradaxa Treatment Requires Kidney Test

(MedPage Today) — The manufacturer of dabigatran etexilate (Pradaxa) will tell European prescribers that renal function testing is a must when starting patients on the drug, under an agreement with the European Union’s top drug regulator.

Ovarian cancer patients with many folate receptors benefit from new therapy

A new strategy that takes advantage of ovarian cancer’s reliance on folate appears to give relapse patients extra months of life with few side effects, researchers say.